Cayman Pharma is one of the world's leading manufacturers of active pharmaceutical ingredients (APIs) produced under the GMP-based prostaglandin regime. Patented prostaglandin synthesis procedures have been used and further developed for more than 20 years at Cayman Pharma s.r.o. near Prague. Compliance with GMP requirements is continuously verified by the Czech regulatory authorities (SÚKL, ÚSKVBL) and the US FDA.